← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

BANK OF INDIA LARGE & MID CAP FUND

Direct Plan · Growth · Mid Cap · Scheme code 119350

Fund houseBank of India Mutual Fund
CategoryMid Cap
Plan & optionDirect · Growth
History13.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.816.035.67 11.6915.8013.46 18.0913.8213.94
Nifty Midcap 150
benchmark
1.724.387.84 13.1317.9318.11 22.88
Mid Cap
category median
10.2119.8417.23 17.08

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 15.9% 0.59 0.80 0.80 -2.31% -37.9% 89.67
Nifty Midcap 150
benchmark
18.3%0.62 0.83 -37.2%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 83 months this scheme and its benchmark share.

Growth of ₹100 since launch

472434396342014201620182020202220242026InvestVerdict

Drawdown from peak (%)

0%-13%-25%-38%2014201620182020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
623 -20.2% 13.2% 70.3% 20%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

BANK OF INDIA LARGE & MID CAP FUND

Direct Plan · Growth

Allocation

By asset

Equity95.69%
Cash & Equivalents4.30%
Debt0.01%

By market cap

Large Cap38.82%
Mid Cap39.32%
Small Cap18.78%
Unclassified0.01%

Concentration

Number of stocks51
Top 5 stocks26.50%
Top 10 stocks42.47%
Top 20 stocks64.57%
Largest holding8.11%
Largest sectorBanks 18.42%
Effective stocks34.1
Cash4.30%
InvestVerdict

BANK OF INDIA LARGE & MID CAP FUND

Direct Plan · Growth · holdings

Top 18 holdings

#CompanySector% of fund
1 Banks8.11%
2 Petroleum Products6.34%
3 Consumer Durables4.33%
4 4.23%
5 Retailing4.18%
6 Banks3.54%
7 Construction3.48%
8 Pharmaceuticals & Biotechnology3.48%
9 Banks3.34%
10 Gas2.88%
11 Financial Technology (Fintech)2.79%
12 Pharmaceuticals & Biotechnology2.50%
13 Diversified FMCG2.44%
14 Banks2.43%
15 Entertainment2.36%
16 Pharmaceuticals & Biotechnology2.33%
17 IT - Software2.27%
18 Retailing2.09%

Sector split

Banks — 18.4%Pharmaceuticals & Biotechnology — 11.7%Retailing — 7.8%Consumer Durables — 7.4%Petroleum Products — 6.3% — 4.2%Construction — 3.6%Financial Technology (Fintech) — 3.3%Auto Components — 3.0%Other — 34.3%Banks18.4%Pharmaceuticals & Biotech…11.7%Retailing7.8%Consumer Durables7.4%Petroleum Products6.3% 4.2%Construction3.6%Financial Technology (Fin…3.3%Auto Components3.0%Other34.3%
Banks18.42%
Pharmaceuticals & Biotechnology11.74%
Retailing7.75%
Consumer Durables7.36%
Petroleum Products6.34%
4.23%
Construction3.57%
Financial Technology (Fintech)3.27%
Auto Components3.00%
Finance2.98%

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹852,054 ₹252,054 14.01%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 31 Aug 2026.